Decline of antimicrobial resistance in <i>Pseudomonas aeruginosa</i> bacteraemia following the COVID-19 pandemic: a longitudinal observational study
We observed a decline in MDRPA occurrence after the start of the COVID-19 pandemic, possibly driven by intensified infection control measures, shifts in antimicrobial use and changes in patient populations.
Authors
- Marc Pfister (ORCID: https://orcid.org/0000-0003-2597-1228)
- Pascal M. Frey (ORCID: https://orcid.org/0000-0001-6161-0919)
- Thomas Scheier (ORCID: https://orcid.org/0000-0001-7805-1025)
- Silvio D. Brugger (ORCID: https://orcid.org/0000-0001-9492-9088)
- Lisa Pagani (ORCID: https://orcid.org/0000-0002-9870-932X)
- Roger D. Kouyos (ORCID: https://orcid.org/0000-0002-9220-8348)
- Stefano Mancini (ORCID: https://orcid.org/0000-0002-3173-1450)
- Yulia Butscheid
- Willy I. Staiger
Institutions
- University of Bern (CH)
- University of Zurich (CH)
- University Hospital of Bern (CH)
- ETH Zurich (CH)
- University Hospital of Zurich (CH)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-04-24
- DOI
- https://doi.org/10.1093/jac/dkaf136
- Citations
- 6
- Primary Topic
- Antibiotic Use and Resistance
- Type
- article
- Field-Weighted Citation Impact
- 7.57
Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Universität Zürich
- Béatrice Ederer-Weber Stiftung